Appointment booking for Dr. Nicholas Gubler, OD is currently not available.Dr. Nicholas Gubler, OD has not yet fully activated their profile on DiabetesIQ.
Dr. Nicholas Gubler, OD (he/him) is a Optometrist in Pasco, WA with over 11 years of experience. What is your opinion of Dr. Nicholas Gubler, OD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 11 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Nicholas Gubler, OD has received over $1,702 which includes payments from the following companies:
$359.73 from Shire North American Group Inc
$351.38 from Allergan Inc.
$189.44 from Mallinckrodt Hospital Products Inc.
$152.91 from Mallinckrodt Enterprises LLC
$140.68 from Genentech USA, Inc.
$111.85 from OPTOS, INC.
$86.24 from Valeant Pharmaceuticals North America LLC
$57.63 from MacuLogix, Inc.
$43.90 from Mallinckrodt LLC
$41.66 from TissueTech, Inc.
$37.11 from Sun Pharmaceutical Industries Inc.
$25.71 from TearLab Corp
$23.30 from Bausch and Lomb Inc.
$19.57 from Dompe US, Inc.
$18.79 from Johnson & Johnson Surgical Vision, Inc.
$16.17 from Alimera Sciences, Inc.
$15.00 from Johnson & Johnson Vision Care, Inc.
$11.38 from Rapid PAthogen Screening, Inc.
Payments received by Dr. Nicholas Gubler, OD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!